Clinical Trial Update: Study on the Effects of Sacubitril/Valsartan on Physical Activity and Sleep in Heart Failure With Reduced Ejection Fraction Patients. [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effects of sacubitril/valsartan on physical activity and sleep in patients with heart failure with reduced ejection fraction; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Heart Failure, Reduced Ejection Fraction | Phase 4 | Status: COMPLETED | Results posted: 2019-04-08